Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial
Bluejay Diagnostics announced the successful enrollment of 624 patients in its SYMON-II pivotal clinical trial evaluating the Symphony IL-6 test for rapid sepsis triage and monitoring. The Company expects to complete enrollment soon, progressing toward clinical validation and FDA regulatory submission to bring its near-patient testing system to mar…